Investor Relations

Listed On The Shanghai Stock Exchange In June 2001, With A Maximum Market Value Of 47.5 Billion

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Subsidiary Obtaining PICS GMP Certification

Time:2025-12-30

JCARE Announcement on the Progress of the Proposed Public Tender of the Acquisition of Equity Interests in Vietnam’s IMP  by Controlled Subsidiary Livzon Group

Time:2025-12-30

JCARE Indicative Announcement on Acceptance of Application for Registration and Marketing Authorization for Drugs

Time:2025-12-24

JCARE Announcement on Obtaining the Approval Notice for Clinical Trial On Drug

Time:2025-12-21

JCARE Announcement on Obtaining Drug Registration Certificate for Pixavir Marboxil Capsules

Time:2025-12-11

Ad hoc announcement pursuant to Art53 LR JCARE Announcement on Inclusion of the Products in the National Reimbursement Drug List

Time:2025-12-08

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Resolutions of 2025 Second Extraordinary General Meeting

Time:2025-11-14

Ad hoc announcement pursuant to Art. 53 LR-JCARE Notice of 2025 Second Extraordinary General Meeting

Time:2025-10-24

Ad hoc announcement pursuant to Art. 53 LR -JCARE 2025 Third Quarterly Report

Time:2025-10-24

Ad hoc announcement pursuant to Art. 53 LR-JCARE 2025 Interim Report

Time:2025-08-22

< 1234...13 >